Halothane anesthesia does not suppress sympathetic activation produced by neuroglucopenia

Area of Science:

• Veterinary Anesthesiology
• Neuroendocrinology
• Autonomic Nervous System Research

Background:

• Understanding the sympathetic nervous system's role in endocrine pancreas regulation is crucial.
• Assessing anesthetic suitability for physiological studies is essential.

Purpose of the Study:

• To evaluate halothane anesthesia's suitability for studying sympathetic control of the endocrine pancreas in dogs.
• To compare sympathetic responses to neuroglucopenia under halothane versus pentobarbital anesthesia.

Main Methods:

• Dogs were anesthetized with halothane (0.8%) or pentobarbital sodium (30 mg/kg).
• Neuroglucopenia was induced using 2-deoxy-D-glucose (2-DG) at 100 mg/kg and 300 mg/kg.
• Plasma epinephrine (EPI), norepinephrine (NE), and glucose levels were measured.

Main Results:

• Halothane anesthesia allowed for sympathetic responses (increased EPI and NE) to 2-DG comparable to conscious dogs.
• Pentobarbital anesthesia blunted the sympathetic response to a lower dose of 2-DG.
• Higher doses of 2-DG elicited larger increases in EPI, NE, and glucose under halothane compared to pentobarbital.

Conclusions:

• Halothane anesthesia (0.8%) is suitable for studying the sympathetic response to neuroglucopenia in dogs.
• Halothane anesthesia preserves the sympathetic nervous system's response to hypoglycemia, unlike pentobarbital.
• These findings support the use of halothane in canine models investigating autonomic control of the endocrine pancreas.